{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T01:47:31Z","timestamp":1788659251702,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Loss-of-function mutations in dual oxidase (DUOX) 2 are the most common genetic variants found in congenital hypothyroidism (CH), and similar mutations have been recently reported in few very-early-onset inflammatory bowel disease (IBD) patients without CH. If <jats:italic>DUOX2<\/jats:italic> variants indeed increase susceptibility for IBD, the enrichment of <jats:italic>DUOX2<\/jats:italic> mutation carriers among CH patients should be reflected in higher risk for developing IBD. Using a database containing health insurance claims data for over 230 million patients in the United States, 42,922 subjects with CH were identified based on strict inclusion criteria using diagnostic codes. For subgroup analysis, CH patients with pharmacy records were stratified as transient or permanent CH based on the absence or presence of levothyroxine treatment, respectively. Patients were matched to an equal-sized, age- and gender-matched non-CH group. Compared to controls, CH patients had a 73% higher overall IBD prevalence (0.52% vs 0.30%; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). The CH-associated relative risk was higher for indeterminate or ulcerative colitis than Crohn\u2019s disease. Patients with transient CH had higher odds for IBD (OR 2.39 (95% CI 1.77\u20133.23) than those with permanent CH (1.69 (95% CI 1.31\u20132.18). We conclude that patients with CH are at an increased risk of developing IBD. The risk was highest for patients with transient CH, for which partial defects in the DUOX2 system are a particularly common finding.<\/jats:p>","DOI":"10.1038\/s41598-018-28586-5","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T09:52:30Z","timestamp":1530265950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Increased risk for inflammatory bowel disease in congenital hypothyroidism supports the existence of a shared susceptibility factor"],"prefix":"10.1038","volume":"8","author":[{"given":"Helmut","family":"Grasberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Noureldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinivas","family":"Bishu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"El-Zaatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1238-8324","authenticated-orcid":false,"given":"John Y.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1964-8790","authenticated-orcid":false,"given":"Akbar K.","family":"Waljee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"key":"28586_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.mce.2010.01.029","volume":"322","author":"H Grasberger","year":"2010","unstructured":"Grasberger, H. Defects of thyroidal hydrogen peroxide generation in congenital hypothyroidism. Mol Cell Endocrinol 322, 99\u2013106 (2010).","journal-title":"Mol Cell Endocrinol"},{"key":"28586_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1056\/NEJMoa012752","volume":"347","author":"JC Moreno","year":"2002","unstructured":"Moreno, J. C. et al. Inactivating mutations in the gene for thyroid oxidase 2 (thox2) and congenital hypothyroidism. N Engl J Med 347, 95\u2013102 (2002).","journal-title":"N Engl J Med"},{"key":"28586_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1055\/s-0042-112224","volume":"48","author":"M Tan","year":"2016","unstructured":"Tan, M. et al. The prevalence, clinical, and molecular characteristics of congenital hypothyroidism caused by duox2 mutations: A population-based cohort study in guangzhou. Horm Metab Res 48, 581\u2013588 (2016).","journal-title":"Horm Metab Res"},{"key":"28586_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3343\/alm.2016.36.2.145","volume":"36","author":"KJ Park","year":"2016","unstructured":"Park, K. J. et al. Duox2 mutations are frequently associated with congenital hypothyroidism in the korean population. Ann Lab Med 36, 145\u2013153 (2016).","journal-title":"Ann Lab Med"},{"key":"28586_CR5","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s40618-015-0382-8","volume":"38","author":"C Fu","year":"2015","unstructured":"Fu, C. et al. Mutation screening of duox2 in chinese patients with congenital hypothyroidism. J Endocrinol Invest 38, 1219\u20131224 (2015).","journal-title":"J Endocrinol Invest"},{"key":"28586_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1515\/jpem-2015-0400","volume":"29","author":"K Matsuo","year":"2016","unstructured":"Matsuo, K. et al. High prevalence of duox2 mutations in japanese patients with permanent congenital hypothyroidism or transient hypothyroidism. J Pediatr Endocrinol Metab 29, 807\u2013812 (2016).","journal-title":"J Pediatr Endocrinol Metab"},{"key":"28586_CR7","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/hmg\/ddx145","volume":"26","author":"T de Filippis","year":"2017","unstructured":"de Filippis, T. et al. A frequent oligogenic involvement in congenital hypothyroidism. Hum Mol Genet 26, 2507\u20132514 (2017).","journal-title":"Hum Mol Genet"},{"key":"28586_CR8","doi-asserted-by":"crossref","unstructured":"Jiang, H., et al. High prevalence of duox2 gene mutations among children with congenital hypothyroidism in central china. Eur J Med Genet 59:526-531 (2016).","DOI":"10.1016\/j.ejmg.2016.07.004"},{"key":"28586_CR9","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1172\/JCI75436","volume":"124","author":"Y Haberman","year":"2014","unstructured":"Haberman, Y. et al. Pediatric crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest 124, 3617\u20133633 (2014).","journal-title":"J Clin Invest"},{"key":"28586_CR10","doi-asserted-by":"crossref","unstructured":"Grasberger, H., et al. Increased expression of duox2 is an epithelial response to mucosal dysbiosis required for immune homeostasis in mouse intestine. Gastroenterology 149, 1849\u20131859 (2015).","DOI":"10.1053\/j.gastro.2015.07.062"},{"key":"28586_CR11","doi-asserted-by":"publisher","first-page":"10406","DOI":"10.1073\/pnas.1605443113","volume":"113","author":"LA Alvarez","year":"2016","unstructured":"Alvarez, L. A. et al. Nadph oxidase-derived h2o2 subverts pathogen signaling by oxidative phosphotyrosine conversion to pb-dopa. Proc Natl Acad Sci USA 113, 10406\u201310411 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28586_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","volume":"134","author":"RB Sartor","year":"2008","unstructured":"Sartor, R. B. Microbial influences in inflammatory bowel diseases. Gastroenterology 134, 577\u2013594 (2008).","journal-title":"Gastroenterology"},{"key":"28586_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jcmgh.2015.06.005","volume":"1","author":"P Hayes","year":"2015","unstructured":"Hayes, P. et al. Defects in nadph oxidase genes nox1 and duox2 in very early onset inflammatory bowel disease. Cell Mol Gastroenterol Hepatol 1, 489\u2013502 (2015).","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"28586_CR14","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1053\/j.gastro.2016.06.040","volume":"151","author":"AP Levine","year":"2016","unstructured":"Levine, A. P. et al. Genetic complexity of crohn\u2019s disease in two large ashkenazi jewish families. Gastroenterology 151, 698\u2013709 (2016).","journal-title":"Gastroenterology"},{"key":"28586_CR15","doi-asserted-by":"crossref","unstructured":"Parlato, M. et al. First identification of biallelic inherited duox2 inactivating mutations as a cause of very early onset inflammatory bowel disease. Gastroenterology (2017).","DOI":"10.1053\/j.gastro.2016.12.053"},{"key":"28586_CR16","doi-asserted-by":"crossref","unstructured":"Jin, H. Y. et al. High frequency of duox2 mutations in transient or permanent congenital hypothyroidism with eutopic thyroid glands. Horm Res Paediatr 82, 252\u2013260 (2014).","DOI":"10.1159\/000362235"},{"key":"28586_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1530\/EJE-15-0959","volume":"174","author":"Y Maruo","year":"2016","unstructured":"Maruo, Y. et al. Natural course of congenital hypothyroidism by dual oxidase 2 mutations from the neonatal period through puberty. Eur J Endocrinol 174, 453\u2013463 (2016).","journal-title":"Eur J Endocrinol"},{"key":"28586_CR18","first-page":"e162","volume":"115","author":"RE Enacan","year":"2017","unstructured":"Enacan, R. E. et al. [transient congenital hypothyroidism due to biallelic defects of duox2 gene. Two clinical cases]. Arch Argent Pediatr 115, e162\u2013e165 (2017).","journal-title":"Two clinical cases]. Arch Argent Pediatr"},{"key":"28586_CR19","doi-asserted-by":"publisher","first-page":"5187061","DOI":"10.1155\/2016\/5187061","volume":"2016","author":"T Shizuma","year":"2016","unstructured":"Shizuma, T. Concomitant thyroid disorders and inflammatory bowel disease: A literature review. Biomed Res Int 2016, 5187061 (2016).","journal-title":"Biomed Res Int"},{"key":"28586_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.0954-6820.1975.tb04882.x","volume":"197","author":"G Jarnerot","year":"1975","unstructured":"Jarnerot, G., Azad Khan, A. K. & Truelove, S. C. The thyroid in ulverative colitis and crohn\u2019s disease. Ii. Thyroid enlargement and hyperthyroidism in ulcerative colitis. Acta Med Scand 197, 83\u201387 (1975).","journal-title":"Acta Med Scand"},{"key":"28586_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2431-10-9","volume":"10","author":"AR Kemper","year":"2010","unstructured":"Kemper, A. R., Ouyang, L. & Grosse, S. D. Discontinuation of thyroid hormone treatment among children in the united states with congenital hypothyroidism: Findings from health insurance claims data. BMC Pediatr 10, 9 (2010).","journal-title":"BMC Pediatr"},{"key":"28586_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"28586_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.beem.2017.04.006","volume":"31","author":"M Muzza","year":"2017","unstructured":"Muzza, M. & Fugazzola, L. Disorders of h2o2 generation. Best Pract Res Clin Endocrinol Metab 31, 225\u2013240 (2017).","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"28586_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1210\/jc.2007-2020","volume":"93","author":"I Zamproni","year":"2008","unstructured":"Zamproni, I. et al. Biallelic inactivation of the dual oxidase maturation factor 2 (duoxa2) gene as a novel cause of congenital hypothyroidism. J Clin Endocrinol Metab 93, 605\u2013610 (2008).","journal-title":"J Clin Endocrinol Metab"},{"key":"28586_CR25","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1210\/jc.2017-00529","volume":"102","author":"Z Aycan","year":"2017","unstructured":"Aycan, Z. et al. Digenic duox1 and duox2 mutations in cases with congenital hypothyroidism. J Clin Endocrinol Metab 102, 3085\u20133090 (2017).","journal-title":"J Clin Endocrinol Metab"},{"key":"28586_CR26","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1007\/s10620-014-3174-7","volume":"59","author":"JK Hou","year":"2014","unstructured":"Hou, J. K. et al. Accuracy of diagnostic codes for identifying patients with ulcerative colitis and crohn\u2019s disease in the veterans affairs health care system. Dig Dis Sci 59, 2406\u20132410 (2014).","journal-title":"Dig Dis Sci"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28586-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28586-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28586-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:08:19Z","timestamp":1671606499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28586-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["28586"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-28586-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,5]]},"assertion":[{"value":"2 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J. M. L. consults for Unitio. Other authors have no disclosure to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10158"}}